<DOC>
	<DOCNO>NCT01059266</DOCNO>
	<brief_summary>This study investigate safety two up-dosing regimen . The safety PURETHAL Grasses evaluate rush regimen ( maximum dose reach 3 injection 2 week ) compare conventional regimen ( maximum dose reach 6 injection 5 week ) . The primary parameter proportion patient experience systemic reaction &gt; grade I within 24 hour injection need 2 additional injection up-dosing phase maintenance dose reach . It expect up-dosing PURETHAL Grasses accord rush regimen safe use conventional regimen .</brief_summary>
	<brief_title>PURETHAL Grasses Rush Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>Inclusion Criteria Patients rhinitis rhinoconjunctivitis , without mild asthma ( FEV1 &gt; 70 % ) least 2 year related grass pollen , eligible SCIT . Confirmation IgEmediated allergy mean : Positive SPT grass pollen ( mean wheal diameter ≥ 3 mm negative control truly negative ( reaction ) , Specific serum IgEtest ( ssIgE &gt; 0.7 U/ml ) grass pollen , Positive provocation test grass pollen . Age ≥ 18 year . Patients give write informed consent Chronic asthma emphysema , particularly FEV1 ≤ 70 % predict value . Serious immunopathological disease malignancy ( include autoimmune disease , tuberculosis , HIV ) . Active inflammation/infection target organ ( nose , eye , lung ) . Severe atopic dermatitis need systemic immunosuppressive medication . Symptomatic coronary heart disease ( e.g heart failure , recent myocardial infarction , unstable angina , serious arrhythmia ) severe ( even treatment ) arterial hypertension . Severe kidney disease . Diseases contraindication use adrenaline . Treatment systemic local betablockers immunosuppressive drug . History life threaten anaphylactic event , include anaphylactic food allergy , insect venom anaphylaxis , exercise drug induce anaphylaxis . Any specific immunotherapy ( include sublingual ) study period previous 3 year period longer three month . Participation clinical study new investigational drug within last three month . Pregnancy , lactation inadequate contraceptive measure ( adequate measure : oral contraceptive , IUD , condom use use together spermicide sexual relationship man ) . Alcohol drug abuse . Lack cooperation severe psychological disorder . Completed ongoing longterm treatment tranquilizer psycho active drug . Low compliance inability understand instructions/study document . Completed ongoing treatment antiIgEantibody . Patients relationship dependence sponsor investigator . Allergy excipients . Severe illness condition , make patient , opinion investigator , unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>immunotherapy</keyword>
	<keyword>grass pollen</keyword>
	<keyword>seasonal allergy</keyword>
	<keyword>dose tolerability</keyword>
</DOC>